濮阳东方医院看妇科病专业濮阳东方看妇科病评价很不错,濮阳东方看妇科病可靠,濮阳东方医院男科治阳痿方法,濮阳东方男科医院治病专业,濮阳东方看男科评价很高,濮阳东方医院看妇科口碑评价很好,濮阳东方男科医院好么

"Target has received 14 reports of the cables smoking, sparking or igniting, including two reports of consumer finger burns." —CPSC 139

(AP) -- California Gov. Gavin Newsom says the state will halt sales of new gasoline-powered passenger cars and trucks by 2035.On Wednesday, he ordered state regulators to come up with requirements to meet that goal. California would be the first state with such a rule, though Germany and France are among 15 other countries that have a similar requirement.Newsom's plan would not ban people from owning gas-powered cars or selling them on the used car market, but it would end the sales of all new gasoline-powered passenger cars and trucks in the state.California already has rules mandating a certain percentage of new car sales be electric or zero-emission vehicles. 678

(CNN) -- Drone strikes on Saudi Arabian oil facilities have disrupted about half of the kingdom's oil capacity, or 5% of the daily global oil supply, people with knowledge of Saudi's oil operations told CNN Business.Yemen's Houthi rebels on Saturday took responsibility for the attacks, saying 10 drones targeted state-owned Saudi Aramco oil facilities in Abqaiq and Khurais, according to the Houthi-run Al-Masirah news agency.Five million barrels per day of crude production have been impacted after fires raged at the sites, one of them the world's largest oil production facility, people with knowledge of the kingdom's operations said. The latest OPEC figures from August 2019 put the total Saudi production at 9.8 million barrels per day.A source told CNN Business that Aramco "hopes to have that capacity restored within days."The Saudi interior ministry confirmed the drone attacks caused fires at the two facilities. In a statement posted on Twitter, the ministry said the fires were under control and that authorities were investigating."Abqaiq is perhaps the most critical facility in the world for oil supply. Oil prices will jump on this attack," Jason Bordoff, founding director of the Center on Global Energy Policy at Columbia University, said in a statement.The development comes as Saudi Aramco takes steps to go public in what could be the world's biggest IPO. Aramco attracted huge interest with its debut international bond sale in April. It commissioned an independent audit of the kingdom's oil reserves and has started publishing earnings. Over the past two weeks, the kingdom has replaced its energy minister and the chairman of Aramco.Saudi Arabia, the world's largest oil exporter, has cut back on production of crude and other energy products as part of an OPEC effort to boost prices. Saudi Arabia produces approximately 10% of the total global supply of 100 million barrels per day.The International Energy Agency said on Saturday it was monitoring the situation in Saudi Arabia. "We are in contact with Saudi authorities as well as major producer and consumer nations. For now, markets are well supplied with ample commercial stocks," it said on Twitter.If the disruption in Saudi Arabia is prolonged, "sanctioned Iran supplies are another source of potential additional oil," Bordoff said. "But [US President Donald]Trump has already shown he is willing to pursue a maximum pressure campaign even when oil prices spike. If anything, the risk of tit-for-tat regional escalation that pushes oil prices even higher has gone up significantly."Oil prices fell on Friday, with Brent crude, the global price benchmark slipping 0.3% to close at .22 per barrel. 2694

"Curiosity. InSight. Spirit. Opportunity. If you think about it, all of these names of past Mars rovers are qualities we possess as humans. We are always curious, and seek opportunity. We have the spirit and insight to explore the Moon, Mars, and beyond. But, if rovers are to be the qualities of us as a race, we missed the most important thing. Perseverance. We as humans evolved as creatures who could learn to adapt to any situation, no matter how harsh. We are a species of explorers, and we will meet many setbacks on the way to Mars. However, we can persevere. We, not as a nation but as humans, will not give up. The human race will always persevere into the future." 683

(AP) - With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics.The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the science, manufacturing and sale of cannabis compounds like CBD.In the meantime, it issued more warning letters to companies for making unapproved health claims about CBD products.Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist.RELATED: Can using CBD products cost someone their job? A look at what we know as U.S. regulators work out what will and won't be allowed:WHAT IS CBD?CBD is one of more than 100 compounds found in marijuana. It's extracted using alcohol or carbon dioxide in factories. It's added to oils, mixed into creams and lotions and sold in candies and liquid drops.Widely sold online, CBD now is going mainstream with major retailers offering salves and balms for the skin. Prices range from to 0 an ounce at high-end shops.CBD often comes from a cannabis plant known as hemp, which is defined by the U.S. government as having less than 0.3 percent THC. That's important because THC is what causes marijuana's mind-altering effect.CBD doesn't get people high, although it may be calming. Keep in mind some CBD products may contain THC, whether or not the label says so.RELATED: CBD-infused foods become rising trend in 2019People drug tested for work, addiction programs or because they take prescription opioids should take note: CBD products have caused people to fail urine drug screens.IS IT A MIRACLE CURE?If you believe the hype, CBD treats pain, relieves anxiety and both helps you sleep and keeps you focused.Most claims are based on studies in rats, mice or in test tubes. Some human research has been done, but in small numbers of people.One exception: For two rare seizure disorders, the evidence for CBD was strong enough to convince the FDA to approve GW Pharmaceutical's drug Epidiolex, which contains a purified form.The FDA announced Tuesday it has sent warning letters to three companies marketing products with what outgoing Commissioner Scott Gottlieb called "egregious, over-the-line claims" for CBD's effects on cancer, Alzheimer's disease, fibromyalgia and drug addiction. Gottlieb said the agency "won't tolerate this kind of deceptive marketing to vulnerable patients."RELATED: CVS Pharmacy selling cannabis-based products in stores in California, 7 other statesOnly drugs that have been reviewed by the FDA as safe and effective can make claims that they treat or prevent diseases or medical conditions. Many CBD producers attempt to sidestep the issue by using only vague language about general health and well-being.ANY SIDE EFFECTS?Scant research means not much is known about side effects either. In epilepsy research, CBD changed the way the body processed other drugs. That suggests CBD could interact with medications in ways we still don't know about.The most common side effects of the CBD drug Epidiolex include sleepiness, decreased appetite, diarrhea, increases in liver enzymes, exhaustion, rash and infections. FDA's Gottlieb noted Tuesday the potential for liver injury and other risks can be handled with medical supervision but less is known about how that would be managed without oversight. And there are questions about overlap if multiple CBD products are used.IS IT LEGAL?For now, the agency has said CBD is not allowed as an ingredient in food, drinks or dietary supplements.In stating its position, the FDA cited a provision of the law prohibiting food makers from using active drug ingredients or those that are the subject of substantial research. But the agency doesn't have the resources to police all the CBD products that are already available, said Marc Scheineson, a former FDA official.RELATED: Creator of Jelly Belly releases CBD-infused jelly beans"They're not going to pull a thousand products from the market," he said.The FDA's authority is over interstate commerce, and local officials have taken differing approaches. In New York, Los Angeles and elsewhere, officials are warning eateries to stop selling it in food and drinks. Maine passed a law allowing it in foods and other products in the state.Skin creams and cosmetics may be on safer footing with the FDA, but that too remains uncertain, said Camille Gourdet of RTI International, a nonprofit research institute in Durham, North Carolina. Though cosmetics aren't subject to premarket approval by the FDA, they could run afoul of regulations if they make specific health claims.Marijuana itself is illegal under federal law; most states that have legalized it allow marijuana-infused foods and candies, called edibles.ARE CBD LABELS ACCURATE?What you buy may contain much less CBD than the label states — or much more. It may include more THC than you want and it may be contaminated with mold or pesticides. Ask to see testing reports.A 2017 study in the Journal of the American Medical Association found 70 percent of CBD products were mislabeled. Researchers used an independent lab to test 84 products from 31 companies."You're really flying by the seat of your pants when you buy this stuff," said author Marcel Bonn-Miller of University of Pennsylvania.A product labeled as containing 100 milligrams of CBD may only have 5 milligrams or it may have 200, said Bonn-Miller, now an adviser for a company that sells CBD and other cannabis products. He did not work in the industry when he did the research."I wouldn't trust any of it until I knew independently it was safe," Bonn-Miller said.WHAT'S AHEAD?CBD research is planned or underway for cancer, autism, diabetic neuropathy, fibromyalgia, chronic pain, alcoholism with PTSD and psychiatric conditions. Results will take years, but some people aren't waiting."They are vulnerable and really hoping to feel better," said Karen Hande, a nurse practitioner at Vanderbilt-Ingram Cancer Center in Nashville.She became an expert in CBD because so many of her cancer patients were trying it. She tells them the evidence isn't enough to back the claims, but "they want to believe something is going to work." 6383